Tonix Pharmaceuticals
TNXP
#8855
Rank
S$0.29 B
Marketcap
S$17.33
Share price
9.72%
Change (1 day)
-61.01%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -S$0.19 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are S$17.55 Million. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$95.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.19 Billion23.11%
2025 -S$0.16 Billion61.37%
2024 -S$95.4 Million-36.5%
2023 -S$0.16 Billion5.61%
2022 -S$0.15 Billion21.43%
2021 -S$0.12 Billion82.76%
2020 -S$64.1 Million75.22%
2019 -S$36.59 Million9.52%
2018 -S$33.41 Million23.63%
2017 -S$27.02 Million-45.36%
2016 -S$49.46 Million-19.09%
2015 -S$61.12 Million74.15%
2014 -S$35.1 Million153.99%
2013 -S$13.82 Million
2011 -S$6.67 Million29538.74%
2010 -S$0.03 Million-42.58%
2009 -S$0.04 Million46.05%
2008 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-S$29.5 Million-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
S$45.25 M-124.14%๐Ÿ‡บ๐Ÿ‡ธ USA